State Street Corp Clovis Oncology, Inc. Transaction History

State Street Corp

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 15, 2022	BUY	$1.05 - $2.85 $117,075 - $317,775	111,500 Added 18.46%	715,398 $851,000
Q2 2022 Aug 15, 2022	SELL	$0.63 - $2.96 $1.27 Million - $5.97 Million	-2,015,579 Reduced 76.95%	603,898 $1.09 Million
Q1 2022 May 16, 2022	SELL	$1.43 - $3.14 $19.3 Million - $42.4 Million	-13,495,065 Reduced 83.74%	2,619,477 $5.29 Million
Q4 2021 Feb 14, 2022	BUY	$2.7 - $4.76 $3.89 Million - $6.85 Million	1,439,788 Added 9.81%	16,114,542 $43.7 Million
Q3 2021 Nov 15, 2021	BUY	$4.06 - $5.8 $19.3 Million - $27.6 Million	4,758,189 Added 47.98%	14,674,754 $65.4 Million
Q2 2021 Aug 16, 2021	BUY	$5.02 - $7.05 $118,913 - $167,000	23,688 Added 0.24%	9,916,565 $57.5 Million
Q1 2021 May 17, 2021	SELL	$4.81 - $10.34 $22.3 Million - $48 Million	-4,642,995 Reduced 31.94%	9,892,877 $69.4 Million
Q4 2020 Feb 16, 2021	BUY	$4.13 - $6.41 $20.2 Million - $31.3 Million	4,889,142 Added 50.68%	14,535,872 $69.8 Million
Q3 2020 Nov 10, 2020	BUY	$4.82 - $7.72 $1.97 Million - $3.15 Million	407,999 Added 4.42%	9,646,730 $56.2 Million
Q2 2020 Aug 14, 2020	BUY	$5.69 - $9.69 $31.7 Million - $54 Million	5,568,480 Added 151.72%	9,238,731 $62.4 Million
Q1 2020 May 11, 2020	BUY	$3.77 - $11.0 $13.8 Million - $40.4 Million	3,670,251 New	3,670,251 $23.3 Million

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.